Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Papapoulos

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 19, 2010
Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group ReportR Rizzoli, K Akesson, M Bouxsein, et al.
Endocrinology|September 1, 1991
Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrixG van der Pluijm, W Most, L van der Wee-Pals, et al.
The Journal of Clinical Investigation|August 1, 1996
Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitroG van der Pluijm, H Vloedgraven, E van Beek, et al.
Bone Reports|December 16, 2016
Technical note: Recommendations for a standard procedure to assess cortical bone at the tissue-level in vivo using impact microindentationA Diez-Perez, M L Bouxsein, E F Eriksen, et al.
Clinical Therapeutics|August 10, 1999
Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical GuidelinesP J Meunier, P D Delmas, R Eastell, et al.
Calcified Tissue International|March 28, 2012
Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paperJ Goldhahn, J-M Féron, J Kanis, et al.
Arthritis and Rheumatism|March 1, 1995
Prednisone treatment of elderly-onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatmentD van Schaardenburg, R Valkema, B A Dijkmans, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1992
Disodium 1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonate (EB-1053) is a potent inhibitor of bone resorption in vitro and in vivoG van der Pluijm, L Binderup, E Bramm, et al.
Bone|July 1, 1995
Effects of experimental conditions on the release of 45calcium from prelabeled fetal mouse long bonesE van Beek, M Oostendorp-van de Ruit, L van der Wee-Pals, et al.
Journal of Developmental Physiology|April 1, 1982
Calcium homeostasis in the fetal pigA D Care, R Ross, D W Pickard, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 19, 2010
Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group ReportR Rizzoli, K Akesson, M Bouxsein, et al.
Endocrinology|September 1, 1991
Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrixG van der Pluijm, W Most, L van der Wee-Pals, et al.
The Journal of Clinical Investigation|August 1, 1996
Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitroG van der Pluijm, H Vloedgraven, E van Beek, et al.
Bone Reports|December 16, 2016
Technical note: Recommendations for a standard procedure to assess cortical bone at the tissue-level in vivo using impact microindentationA Diez-Perez, M L Bouxsein, E F Eriksen, et al.
Clinical Therapeutics|August 10, 1999
Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical GuidelinesP J Meunier, P D Delmas, R Eastell, et al.
Calcified Tissue International|March 28, 2012
Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paperJ Goldhahn, J-M Féron, J Kanis, et al.
Arthritis and Rheumatism|March 1, 1995
Prednisone treatment of elderly-onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatmentD van Schaardenburg, R Valkema, B A Dijkmans, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1992
Disodium 1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonate (EB-1053) is a potent inhibitor of bone resorption in vitro and in vivoG van der Pluijm, L Binderup, E Bramm, et al.
Bone|July 1, 1995
Effects of experimental conditions on the release of 45calcium from prelabeled fetal mouse long bonesE van Beek, M Oostendorp-van de Ruit, L van der Wee-Pals, et al.
Journal of Developmental Physiology|April 1, 1982
Calcium homeostasis in the fetal pigA D Care, R Ross, D W Pickard, et al.
Pageof 5